Evaluation of Serum Concentration of the Myokine Irisin (FNDC5) in Patients with Age-Related.

Objectives: This study evaluated the serum irisin level of patients with age-related macular degeneration (ARMD) and compared it with that of healthy individuals.

Methods: The serum irisin level of 15 healthy controls (Group 1) and 15 dry ARMD patients (Group 2) and 15 wet ARMD patients (Group 3) were measured using the enzyme-linked immunosorbent assay (ELISA) method and compared.

Results: There was no statistically significant difference between the groups in terms of age or gender (p>0.